Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucagonomas and insulinomas.

G Boden1

  • 1Department of Medicine, Temple University Hospital, Philadelphia, Pennsylvania.

Gastroenterology Clinics of North America
|December 1, 1989
PubMed
Summary
This summary is machine-generated.

This study details glucagonoma and insulinoma syndromes, covering their clinical features, diagnosis, and treatment. It also examines tumor prevalence, distribution, malignancy, and localization for better understanding.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Central administration of vaspin inhibits glucose production and augments hepatic insulin signaling in high-fat-diet-fed rat.

International journal of obesity (2005)·2016
Same author

Transcription factor TIP27 regulates glucose homeostasis and insulin sensitivity in a PI3-kinase/Akt-dependent manner in mice.

International journal of obesity (2005)·2015
Same author

Effect of dietary fat and food consistency on gastroparesis symptoms in patients with gastroparesis.

Neurogastroenterology and motility·2015
Same author

Bodyweight in patients with idiopathic gastroparesis: roles of symptoms, caloric intake, physical activity, and body metabolism.

Neurogastroenterology and motility·2013
Same author

The rhPTH treatment elevates plasma secreted protein acidic and rich in cysteine levels in patients with osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2012
Same author

Changes in serum runt-related transcription factor 2 levels after a 6-month treatment with recombinant human parathyroid hormone in patients with osteoporosis.

Journal of endocrinological investigation·2011
Same journal

Living Donor Intestinal and Liver Transplantation.

Gastroenterology clinics of North America·2026
Same journal

Living Abdominal Organ Donation: A Plan B That Saves Lives.

Gastroenterology clinics of North America·2026
Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026
Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026
See all related articles

Area of Science:

  • Endocrinology
  • Oncology
  • Surgical Pathology

Background:

  • Glucagonoma and insulinoma are rare neuroendocrine tumors.
  • These tumors present distinct clinical syndromes with significant diagnostic and therapeutic challenges.

Purpose of the Study:

  • To provide a comprehensive overview of glucagonoma and insulinoma syndromes.
  • To describe the clinical features, diagnosis, differential diagnosis, and treatment modalities.
  • To detail the epidemiology, including prevalence, distribution, malignancy, and localization of these tumors.

Main Methods:

  • Literature review and synthesis of existing data.
  • Analysis of clinical presentations and diagnostic criteria.
  • Review of treatment strategies and prognostic factors.

Related Experiment Videos

Main Results:

  • Detailed description of the characteristic clinical manifestations of each syndrome.
  • Discussion of diagnostic approaches, including biochemical and imaging techniques.
  • Information on the typical locations, malignant potential, and epidemiological data.

Conclusions:

  • Accurate diagnosis and timely management are crucial for improving patient outcomes.
  • Understanding the specific features of glucagonoma and insulinoma is essential for effective clinical practice.
  • Further research may elucidate more targeted therapeutic strategies.